Xenon Pharmaceuticals Inc at Bloom Burton & Co Healthcare Investor Conference Transcript
We have Xenon Pharmaceuticals. And we have Ian Mortimer, President and CEO. Take it away, Ian.
Thanks, Andrew. Good morning, everyone, and thanks for joining. It's been -- it's great to be back at the Bloom Burton conference. Lot of progress at Xenon over the last years, so nice opportunity to give you an update on.
I will be making some forward-looking statements, so I do refer you to our full risk factor disclosure filed with the SEC and also filed on SEDAR.
For those that are newer to the Xenon's story, we're a neurology company. We've built really strong capabilities of drugging ion channels in the CNS. We've been doing this for about 15 years or so.
Over the last number of years, we've built really strong capabilities in epilepsy drug development from preclinical modeling and pharmacology, all the way through clinical development. And our goal strategically is to forward integrate into a commercial organization, and we plan to launch our lead program
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
